DAURISMO™ What is DAURISMO?

(glasdegib)

What is DAURISMO?

•
are 75 years of age or older, or
•
have other medical conditions that prevent the use of standard chemotherapy.

It is not known if DAURISMO is safe and effective in children.

Before you take DAURISMO, tell your healthcare provider about all of your medical conditions, including if you:

•
have heart problems, including a condition called long QT syndrome.
•
abnormal blood salt (electrolytes) levels.
•
have muscle pain or spasms.
•
have kidney problems.
•
are pregnant or plan to become pregnant. See "What is the most important information I should know about DAURISMO?"
•
are breastfeeding or plan to breastfeed. It is not known if DAURISMO passes into your breast milk. Do not breastfeed or provide breast milk to infants or children during treatment with DAURISMO and for at least 30 days after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

Find DAURISMO™ medical information:

Find DAURISMO™ medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

DAURISMO™ Quick Finder

Medication Guide

Health Professional Information

What is DAURISMO?

What is DAURISMO?

•
are 75 years of age or older, or
•
have other medical conditions that prevent the use of standard chemotherapy.

It is not known if DAURISMO is safe and effective in children.

Before you take DAURISMO, tell your healthcare provider about all of your medical conditions, including if you:

•
have heart problems, including a condition called long QT syndrome.
•
abnormal blood salt (electrolytes) levels.
•
have muscle pain or spasms.
•
have kidney problems.
•
are pregnant or plan to become pregnant. See "What is the most important information I should know about DAURISMO?"
•
are breastfeeding or plan to breastfeed. It is not known if DAURISMO passes into your breast milk. Do not breastfeed or provide breast milk to infants or children during treatment with DAURISMO and for at least 30 days after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

Prescribing Information
Download Prescribing Information

Health Professional Information

What is DAURISMO?

What is DAURISMO?

•
are 75 years of age or older, or
•
have other medical conditions that prevent the use of standard chemotherapy.

It is not known if DAURISMO is safe and effective in children.

Before you take DAURISMO, tell your healthcare provider about all of your medical conditions, including if you:

•
have heart problems, including a condition called long QT syndrome.
•
abnormal blood salt (electrolytes) levels.
•
have muscle pain or spasms.
•
have kidney problems.
•
are pregnant or plan to become pregnant. See "What is the most important information I should know about DAURISMO?"
•
are breastfeeding or plan to breastfeed. It is not known if DAURISMO passes into your breast milk. Do not breastfeed or provide breast milk to infants or children during treatment with DAURISMO and for at least 30 days after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.